PrecisionLife: learning from genetic interactions by cutting noise

Having pivoted from providing software to delivering target and biomarker insights via its 2019 reboot, PrecisionLife is untangling the biological networks behind complex diseases using a dimensionality reduction approach borrowed from other industries.

PrecisionLife Ltd. co-founder and CEO Steve Gardner told BioCentury the company’s core methodology, known as array-based logic, has a track record of making “high dimensional problem spaces” computationally tractable. An analogy could be coordinating trains on complex railway networks...